#33 - Building the next TechBio venture - Mati Gill - AION Labs

Impulse - Meeting Healthcare Pioneers

Content provided by Mathieu Chaffard. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mathieu Chaffard or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

12M ago 53:16

MP3•Episode home

AI and computational science are revolutionizing the biotechnology sector.

From identifying new therapeutic approaches to their production and accelerating the administrative processes for bringing them to market, the entire value chain of this sector is impacted!

These recent advancements have given rise to a new field in the industry: TechBio.

But what lies behind this futuristic term?

And how exactly do these technologies accelerate the development and introduction of new treatments?

These two questions are at the heart of this episode featuring Mati Gill from AION Labs.

With a background in law and in the pharmaceutical industry, Mati is the CEO of this venture builder focused on this emerging field, at the cutting edge of computer science and biology.

A true startup factory for TechBio, formed around partnerships with the world's largest Tech and Biotechnology companies.

Unlike conventional innovation platforms such as incubators or startup accelerators, AION Labs enables Founders to accelerate the development of their companies through a holistic range of services and tools:

Anchoring the startup’s mission around a clear R&D issue identified by industrial partners
Funding new ventures at the pre-seed or seed stage
Assisting Founders in identifying and recruiting talent
Providing the infrastructure and resources necessary for co-developing new solutions with industrial partners

A masterclass on innovation in TechBio and what this industry will change for health and patients soon!

Timeline:

00:00:00 - Mati’s background from studying law to entering the TechBio field

00:07:00 - A new way to discover medical treatments and drugs

00:12:42 - The current impact of TechBio on the pharmaceutical industry

00:15:58 - The attitude of regulators toward TechBio and how they adapt to it

00:19:00 - Breaking down fantasies around TechBio and its promises

00:23:54 - AION Lab’s operating model and how to build the next TechBio success

00:34:06 - Relationships and investments between startups and partners from AION Labs

00:41:30 - Advice for TechBio enthusiasts and future entrepreneurs in the field

What we also talked about with Mati:

We cited with Mati some of the past episodes of the series:

#8 - Using organoids to transform drug discovery - Nikolce Gjorevski - Roche

This episode was made possible with the support of HLTH Europe!

As Mati mentioned during the episode, you can learn more about the latest in TechBio through Christian Tidona’s work with Biomed X.

You can follow AION Labs’ activities on LinkedIn and X, and get in touch with Mati via LinkedIn.

If you want to give me feedback on the episode or suggest potential guests, contact me over LinkedIn or via email!

And if you liked the episode, please share it, subscribe to the podcast, and leave a 5-star review on streaming platforms! 🙏

Lastly, don’t forget to follow our activities on LinkedIn and our website!

95 episodes

#Tech #Fitness #Medicine #Mathieu Chaffard #Careers #Business #Streaming Platforms